The National Health Surveillance Agency institutes its new Innovation Policy
Ordinance 1,100/2023, which establishes the Innovation Policy of the National Health Surveillance Agency (Anvisa), was published last Monday in the Federal Official Gazette (DOU). Among the document's objectives are: the promotion of efficient institutional results; the development of products and services subject to health surveillance that are based on new technologies; and the improvement of Anvisa's capacity to deal with complex issues.
read +